カテゴリー： GlobalInfoResearch, 世界

皮膚疾患薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Dermatological Disorders Medications Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102965）・商品コード：GIR9102965
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月24日（※2024年版があります。お問い合わせください）
・ページ数：121
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、皮膚疾患薬の世界市場について調べ、まとめました。種類別セグメントは、処方薬、市販薬等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。皮膚疾患薬の世界市場概観、メーカー動向、メーカー別皮膚疾患薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・皮膚疾患薬の市場概観
・皮膚疾患薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・皮膚疾患薬の企業別販売動向、市場シェア、市場集中度、競争動向
・皮膚疾患薬の世界市場規模
・皮膚疾患薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・皮膚疾患薬のアメリカ市場規模推移
・皮膚疾患薬のカナダ市場規模推移
・皮膚疾患薬のメキシコ市場規模推移
・皮膚疾患薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・皮膚疾患薬のドイツ市場規模推移
・皮膚疾患薬のイギリス市場規模推移
・皮膚疾患薬のロシア市場規模推移
・皮膚疾患薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・皮膚疾患薬の日本市場規模推移
・皮膚疾患薬の中国市場規模推移
・皮膚疾患薬の韓国市場規模推移
・皮膚疾患薬のインド市場規模推移
・皮膚疾患薬の東南アジア市場規模推移
・皮膚疾患薬の南米市場分析（ブラジル、アルゼンチン等）
・皮膚疾患薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・皮膚疾患薬の種類別分析/販売量、売上、市場シェア（処方薬、市販薬）
・皮膚疾患薬の用途別分析/市場規模（病院薬局、オンライン薬局、小売薬局）
・皮膚疾患薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・皮膚疾患薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications.

Scope of the Report:
The worldwide market for Dermatological Disorders Medications is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Dermatological Disorders Medications in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Mylan Pharmaceuticals
Pfizer
Roche
Almirall
Bausch Health
Barrier Therapeutics
PharmaDerm
Bristol-Myers Squibb
Galderma
GlaxoSmithKline
Novartis
Sinclair Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Prescription Drugs
Over-The-Counter Drugs

Market Segment by Applications, can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatological Disorders Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatological Disorders Medications, with price, sales, revenue and global market share of Dermatological Disorders Medications in 2017 and 2018.
Chapter 3, the Dermatological Disorders Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatological Disorders Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Dermatological Disorders Medications market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Dermatological Disorders Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Dermatological Disorders Medications Introduction
1.2 Market Analysis by Type
1.2.1 Prescription Drugs
1.2.2 Over-The-Counter Drugs
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Mylan Pharmaceuticals
2.1.1 Business Overview
2.1.2 Dermatological Disorders Medications Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Mylan Pharmaceuticals Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Dermatological Disorders Medications Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Roche
2.3.1 Business Overview
2.3.2 Dermatological Disorders Medications Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Almirall
2.4.1 Business Overview
2.4.2 Dermatological Disorders Medications Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Almirall Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bausch Health
2.5.1 Business Overview
2.5.2 Dermatological Disorders Medications Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bausch Health Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Barrier Therapeutics
2.6.1 Business Overview
2.6.2 Dermatological Disorders Medications Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Barrier Therapeutics Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 PharmaDerm
2.7.1 Business Overview
2.7.2 Dermatological Disorders Medications Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 PharmaDerm Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Bristol-Myers Squibb
2.8.1 Business Overview
2.8.2 Dermatological Disorders Medications Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bristol-Myers Squibb Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Galderma
2.9.1 Business Overview
2.9.2 Dermatological Disorders Medications Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Galderma Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 GlaxoSmithKline
2.10.1 Business Overview
2.10.2 Dermatological Disorders Medications Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GlaxoSmithKline Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Novartis
2.11.1 Business Overview
2.11.2 Dermatological Disorders Medications Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Novartis Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Sinclair Pharma
2.12.1 Business Overview
2.12.2 Dermatological Disorders Medications Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Sinclair Pharma Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Dermatological Disorders Medications Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Dermatological Disorders Medications Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Dermatological Disorders Medications Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Dermatological Disorders Medications Manufacturer Market Share in 2018
3.3.2 Top 6 Dermatological Disorders Medications Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Dermatological Disorders Medications Market Analysis by Regions
4.1 Global Dermatological Disorders Medications Sales, Revenue and Market Share by Regions
4.1.1 Global Dermatological Disorders Medications Sales and Market Share by Regions (2014-2019)
4.1.2 Global Dermatological Disorders Medications Revenue and Market Share by Regions (2014-2019)
4.2 North America Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
4.3 Europe Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
4.5 South America Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
5 North America Dermatological Disorders Medications by Country
5.1 North America Dermatological Disorders Medications Sales, Revenue and Market Share by Country
5.1.1 North America Dermatological Disorders Medications Sales and Market Share by Country (2014-2019)
5.1.2 North America Dermatological Disorders Medications Revenue and Market Share by Country (2014-2019)
5.2 United States Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
5.3 Canada Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
5.4 Mexico Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
6 Europe Dermatological Disorders Medications by Country
6.1 Europe Dermatological Disorders Medications Sales, Revenue and Market Share by Country
6.1.1 Europe Dermatological Disorders Medications Sales and Market Share by Country (2014-2019)
6.1.2 Europe Dermatological Disorders Medications Revenue and Market Share by Country (2014-2019)
6.2 Germany Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
6.3 UK Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
6.4 France Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
6.5 Russia Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
6.6 Italy Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
7 Asia-Pacific Dermatological Disorders Medications by Country
7.1 Asia-Pacific Dermatological Disorders Medications Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Dermatological Disorders Medications Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Dermatological Disorders Medications Revenue and Market Share by Country (2014-2019)
7.2 China Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
7.3 Japan Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
7.4 Korea Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
7.5 India Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
8 South America Dermatological Disorders Medications by Country
8.1 South America Dermatological Disorders Medications Sales, Revenue and Market Share by Country
8.1.1 South America Dermatological Disorders Medications Sales and Market Share by Country (2014-2019)
8.1.2 South America Dermatological Disorders Medications Revenue and Market Share by Country (2014-2019)
8.2 Brazil Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
8.3 Argentina Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
8.4 Colombia Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
9 Middle East and Africa Dermatological Disorders Medications by Countries
9.1 Middle East and Africa Dermatological Disorders Medications Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Dermatological Disorders Medications Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Dermatological Disorders Medications Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
9.3 Turkey Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
9.4 Egypt Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
9.5 Nigeria Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
9.6 South Africa Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
10 Global Dermatological Disorders Medications Market Segment by Type
10.1 Global Dermatological Disorders Medications Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Dermatological Disorders Medications Sales and Market Share by Type (2014-2019)
10.1.2 Global Dermatological Disorders Medications Revenue and Market Share by Type (2014-2019)
10.2 Prescription Drugs Sales Growth and Price
10.2.1 Global Prescription Drugs Sales Growth (2014-2019)
10.2.2 Global Prescription Drugs Price (2014-2019)
10.3 Over-The-Counter Drugs Sales Growth and Price
10.3.1 Global Over-The-Counter Drugs Sales Growth (2014-2019)
10.3.2 Global Over-The-Counter Drugs Price (2014-2019)
11 Global Dermatological Disorders Medications Market Segment by Application
11.1 Global Dermatological Disorders Medications Sales Market Share by Application (2014-2019)
11.2 Hospital Pharmacies Sales Growth (2014-2019)
11.3 Online Pharmacies Sales Growth (2014-2019)
11.4 Retail Pharmacies Sales Growth (2014-2019)
12 Dermatological Disorders Medications Market Forecast (2019-2024)
12.1 Global Dermatological Disorders Medications Sales, Revenue and Growth Rate (2019-2024)
12.2 Dermatological Disorders Medications Market Forecast by Regions (2019-2024)
12.2.1 North America Dermatological Disorders Medications Market Forecast (2019-2024)
12.2.2 Europe Dermatological Disorders Medications Market Forecast (2019-2024)
12.2.3 Asia-Pacific Dermatological Disorders Medications Market Forecast (2019-2024)
12.2.4 South America Dermatological Disorders Medications Market Forecast (2019-2024)
12.2.5 Middle East and Africa Dermatological Disorders Medications Market Forecast (2019-2024)
12.3 Dermatological Disorders Medications Market Forecast by Type (2019-2024)
12.3.1 Global Dermatological Disorders Medications Sales Forecast by Type (2019-2024)
12.3.2 Global Dermatological Disorders Medications Market Share Forecast by Type (2019-2024)
12.4 Dermatological Disorders Medications Market Forecast by Application (2019-2024)
12.4.1 Global Dermatological Disorders Medications Sales Forecast by Application (2019-2024)
12.4.2 Global Dermatological Disorders Medications Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Dermatological Disorders Medications Picture
Table Product Specifications of Dermatological Disorders Medications
Figure Global Sales Market Share of Dermatological Disorders Medications by Types in 2018
Table Dermatological Disorders Medications Types for Major Manufacturers
Figure Prescription Drugs Picture
Figure Over-The-Counter Drugs Picture
Figure Dermatological Disorders Medications Sales Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Online Pharmacies Picture
Figure Retail Pharmacies Picture
Figure United States Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure France Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure UK Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure China Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure India Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Dermatological Disorders Medications Revenue (Value) and Growth Rate (2014-2024)
Table Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Mylan Pharmaceuticals Dermatological Disorders Medications Type and Applications
Table Mylan Pharmaceuticals Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Dermatological Disorders Medications Type and Applications
Table Pfizer Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Dermatological Disorders Medications Type and Applications
Table Roche Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Almirall Basic Information, Manufacturing Base and Competitors
Table Almirall Dermatological Disorders Medications Type and Applications
Table Almirall Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch Health Basic Information, Manufacturing Base and Competitors
Table Bausch Health Dermatological Disorders Medications Type and Applications
Table Bausch Health Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Barrier Therapeutics Basic Information, Manufacturing Base and Competitors
Table Barrier Therapeutics Dermatological Disorders Medications Type and Applications
Table Barrier Therapeutics Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table PharmaDerm Basic Information, Manufacturing Base and Competitors
Table PharmaDerm Dermatological Disorders Medications Type and Applications
Table PharmaDerm Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Dermatological Disorders Medications Type and Applications
Table Bristol-Myers Squibb Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Galderma Basic Information, Manufacturing Base and Competitors
Table Galderma Dermatological Disorders Medications Type and Applications
Table Galderma Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Dermatological Disorders Medications Type and Applications
Table GlaxoSmithKline Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Dermatological Disorders Medications Type and Applications
Table Novartis Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sinclair Pharma Basic Information, Manufacturing Base and Competitors
Table Sinclair Pharma Dermatological Disorders Medications Type and Applications
Table Sinclair Pharma Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Dermatological Disorders Medications Sales by Manufacturer (2017-2018)
Figure Global Dermatological Disorders Medications Sales Market Share by Manufacturer in 2017
Figure Global Dermatological Disorders Medications Sales Market Share by Manufacturer in 2018
Table Global Dermatological Disorders Medications Revenue by Manufacturer (2017-2018)
Figure Global Dermatological Disorders Medications Revenue Market Share by Manufacturer in 2017
Figure Global Dermatological Disorders Medications Revenue Market Share by Manufacturer in 2018
Figure Top 3 Dermatological Disorders Medications Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Dermatological Disorders Medications Manufacturer (Revenue) Market Share in 2018
Figure Global Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Global Dermatological Disorders Medications Revenue and Growth Rate (2014-2019)
Table Global Dermatological Disorders Medications Sales by Regions (2014-2019)
Table Global Dermatological Disorders Medications Sales Market Share by Regions (2014-2019)
Table Global Dermatological Disorders Medications Revenue by Regions (2014-2019)
Figure Global Dermatological Disorders Medications Revenue Market Share by Regions in 2014
Figure Global Dermatological Disorders Medications Revenue Market Share by Regions in 2018
Figure North America Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Europe Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure South America Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure North America Dermatological Disorders Medications Revenue and Growth Rate (2014-2019)
Table North America Dermatological Disorders Medications Sales by Countries (2014-2019)
Table North America Dermatological Disorders Medications Sales Market Share by Countries (2014-2019)
Figure North America Dermatological Disorders Medications Sales Market Share by Countries in 2014
Figure North America Dermatological Disorders Medications Sales Market Share by Countries in 2018
Table North America Dermatological Disorders Medications Revenue by Countries (2014-2019)
Table North America Dermatological Disorders Medications Revenue Market Share by Countries (2014-2019)
Figure North America Dermatological Disorders Medications Revenue Market Share by Countries in 2014
Figure North America Dermatological Disorders Medications Revenue Market Share by Countries in 2018
Figure United States Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Canada Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Mexico Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Europe Dermatological Disorders Medications Revenue and Growth Rate (2014-2019)
Table Europe Dermatological Disorders Medications Sales by Countries (2014-2019)
Table Europe Dermatological Disorders Medications Sales Market Share by Countries (2014-2019)
Table Europe Dermatological Disorders Medications Revenue by Countries (2014-2019)
Figure Europe Dermatological Disorders Medications Revenue Market Share by Countries in 2017
Figure Europe Dermatological Disorders Medications Revenue Market Share by Countries in 2018
Figure Germany Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure UK Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure France Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Russia Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Italy Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Dermatological Disorders Medications Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Dermatological Disorders Medications Sales by Countries (2014-2019)
Table Asia-Pacific Dermatological Disorders Medications Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Dermatological Disorders Medications Sales Market Share by Countries 2018
Table Asia-Pacific Dermatological Disorders Medications Revenue by Countries (2014-2019)
Figure Asia-Pacific Dermatological Disorders Medications Revenue Market Share by Countries 2018
Figure China Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Japan Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Korea Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure India Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Southeast Asia Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure South America Dermatological Disorders Medications Revenue and Growth Rate (2014-2019)
Table South America Dermatological Disorders Medications Sales by Countries (2014-2019)
Table South America Dermatological Disorders Medications Sales Market Share by Countries (2014-2019)
Figure South America Dermatological Disorders Medications Sales Market Share by Countries in 2018
Table South America Dermatological Disorders Medications Revenue by Countries (2014-2019)
Table South America Dermatological Disorders Medications Revenue Market Share by Countries (2014-2019)
Figure South America Dermatological Disorders Medications Revenue Market Share by Countries in 2018
Figure Brazil Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Argentina Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Colombia Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Dermatological Disorders Medications Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Dermatological Disorders Medications Sales by Countries (2014-2019)
Table Middle East and Africa Dermatological Disorders Medications Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Dermatological Disorders Medications Sales Market Share by Countries in 2018
Table Middle East and Africa Dermatological Disorders Medications Revenue by Countries (2014-2019)
Table Middle East and Africa Dermatological Disorders Medications Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Dermatological Disorders Medications Revenue Market Share by Countries in 2014
Figure Middle East and Africa Dermatological Disorders Medications Revenue Market Share by Countries in 2018
Figure Saudi Arabia Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure UAE Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Egypt Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure Nigeria Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Figure South Africa Dermatological Disorders Medications Sales and Growth Rate (2014-2019)
Table Global Dermatological Disorders Medications Sales by Type (2014-2019)
Table Global Dermatological Disorders Medications Sales Share by Type (2014-2019)
Table Global Dermatological Disorders Medications Revenue by Type (2014-2019)
Table Global Dermatological Disorders Medications Revenue Share by Type (2014-2019)
Figure Global Prescription Drugs Sales Growth (2014-2019)
Figure Global Prescription Drugs Price (2014-2019)
Figure Global Over-The-Counter Drugs Sales Growth (2014-2019)
Figure Global Over-The-Counter Drugs Price (2014-2019)
Table Global Dermatological Disorders Medications Sales by Application (2014-2019)
Table Global Dermatological Disorders Medications Sales Share by Application (2014-2019)
Figure Global Online Pharmacies Sales Growth (2014-2019)
Figure Global Retail Pharmacies Sales Growth (2014-2019)
Figure Global Dermatological Disorders Medications Sales, Revenue and Growth Rate (2019-2024)
Table Global Dermatological Disorders Medications Sales Forecast by Regions (2019-2024)
Table Global Dermatological Disorders Medications Market Share Forecast by Regions (2019-2024)
Figure North America Sales Dermatological Disorders Medications Market Forecast (2019-2024)
Figure Europe Sales Dermatological Disorders Medications Market Forecast (2019-2024)
Figure Asia-Pacific Sales Dermatological Disorders Medications Market Forecast (2019-2024)
Figure South America Sales Dermatological Disorders Medications Market Forecast (2019-2024)
Figure Middle East and Africa Sales Dermatological Disorders Medications Market Forecast (2019-2024)
Table Global Dermatological Disorders Medications Sales Forecast by Type (2019-2024)
Table Global Dermatological Disorders Medications Market Share Forecast by Type (2019-2024)
Table Global Dermatological Disorders Medications Sales Forecast by Application (2019-2024)
Table Global Dermatological Disorders Medications Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List


【掲載企業】

Mylan Pharmaceuticals、Pfizer、Roche、Almirall、Bausch Health、Barrier Therapeutics、PharmaDerm、Bristol-Myers Squibb、Galderma、GlaxoSmithKline、Novartis、Sinclair Pharma、

★調査レポート[皮膚疾患薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102965)販売に関する免責事項を必ずご確認ください。
★調査レポート[皮膚疾患薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 処方皮膚科薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101542 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、処方皮膚科薬の世界市場について調べ、まとめました。種類別セグメントは、経口、局所等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。処方皮膚科薬の世界市場概観、メーカー動向、メーカー別処方皮膚科薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・処方皮膚科薬の市場概観 ・処方皮膚科薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・処方皮膚科薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・処方皮膚科薬の世界市場規模 ・処方皮膚科薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・処方皮膚科薬のアメリカ市場規模推移 ・処方皮膚科薬のカナダ市場規模推移 ・処方皮膚科薬のメキシコ市場規模推移 ・処方皮膚科薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications. Scope of the Report: The worldwide market for Prescription Dermatological Medications is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Prescription Dermatological Medications in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report...
  • 処方関節炎薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101544 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、処方関節炎薬の世界市場について調べ、まとめました。種類別セグメントは、経口、局所等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。処方関節炎薬の世界市場概観、メーカー動向、メーカー別処方関節炎薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・処方関節炎薬の市場概観 ・処方関節炎薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・処方関節炎薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・処方関節炎薬の世界市場規模 ・処方関節炎薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・処方関節炎薬のアメリカ市場規模推移 ・処方関節炎薬のカナダ市場規模推移 ・処方関節炎薬のメキシコ市場規模推移 ・処方関節炎薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms. Scope of the Report: The worldwide market for Prescription Arthritis Medications is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Prescription Arthritis Medications in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type...
  • OTC疼痛薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102937 / GlobalInfoResearch / 2019年9月24日 / 本調査レポートは、OTC疼痛薬の世界市場について調べ、まとめました。種類別セグメントは、アセトアミノフェン、非ステロイド系抗炎症薬（NSAID）等、用途別セグメントは、病院薬局、ドラッグストア、小売店、Eコマース等に区分しました。OTC疼痛薬の世界市場概観、メーカー動向、メーカー別OTC疼痛薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・OTC疼痛薬の市場概観 ・OTC疼痛薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・OTC疼痛薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・OTC疼痛薬の世界市場規模 ・OTC疼痛薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・OTC疼痛薬のアメリカ市場規模推移 ・OTC疼痛薬のカナダ市場規模推移 ・OTC疼痛薬のメキシコ市場規模推移 ・OTC疼痛薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...OTC pain medication can be basically divided into two types: acetaminophen and nonsteroidal anti-inflammatory drugs. Scope of the Report: The worldwide market for OTC Pain Medications is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the OTC Pain Medications in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market...
  • 抗感染薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101543 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、抗感染薬の世界市場について調べ、まとめました。種類別セグメントは、抗ウイルス薬、抗菌薬、抗真菌薬等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。抗感染薬の世界市場概観、メーカー動向、メーカー別抗感染薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・抗感染薬の市場概観 ・抗感染薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・抗感染薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・抗感染薬の世界市場規模 ・抗感染薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・抗感染薬のアメリカ市場規模推移 ・抗感染薬のカナダ市場規模推移 ・抗感染薬のメキシコ市場規模推移 ・抗感染薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright. Scope of the Report: The worldwide market for Anti-Infective Medications is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Anti-Infective Medications in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report...
  • 抗精神病薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102930 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、抗精神病薬の世界市場について調べ、まとめました。種類別セグメントは、選択的セロトニン再取り込み阻害薬（SSRI）、 セロトニンノルエピネフリン再取り込み阻害剤（SNRI）、   三環系抗うつ薬（TCA）、モノアミンオキシダーゼ阻害剤（MAOI）、 モノアミンオキシダーゼ-Aの可逆的阻害剤（RIMA）、四環系抗うつ薬（TeCA）、  ノルアドレナリン作動性および特定のセロトニン作動性、抗うつ薬（NaSSA）等、用途別セグメントは、病院薬局、ドラッグストア、その他等に区分しました。抗精神病薬の世界市場概観、メーカー動向、メーカー別抗精神病薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・抗精神病薬の市場概観 ・抗精神病薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・抗精神病薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・抗精神病薬の世界市場規模 ・抗精神病薬の北米市場分析（アメリカ、カナダ、メキシコ等）...Antipsychotics medication are a group of drugs that are used to treat serious mental health conditions such as psychosis as well as other emotional and mental conditions. Scope of the Report: The worldwide market for Antipsychotic Medications is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Antipsychotic Medications in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes...
  • 精神療法薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101546 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、精神療法薬の世界市場について調べ、まとめました。種類別セグメントは、抗うつ薬、抗精神病薬、抗不安薬、ADHD薬、その他等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。精神療法薬の世界市場概観、メーカー動向、メーカー別精神療法薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・精神療法薬の市場概観 ・精神療法薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・精神療法薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・精神療法薬の世界市場規模 ・精神療法薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・精神療法薬のアメリカ市場規模推移 ・精神療法薬のカナダ市場規模推移 ・精神療法薬のメキシコ市場規模推移 ・精神療法薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...A psychotherapeutics drug is a licensed psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system. Scope of the Report: The worldwide market for Psychotherapeutics Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Psychotherapeutics Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on...
  • 医薬品グレード人造樟脳の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101943 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、医薬品グレード人造樟脳の世界市場について調べ、まとめました。種類別セグメントは、純度98％、純度99％、その他等、用途別セグメントは、呼吸器疾患、筋肉リウマチ、反刺激性および鎮痒薬、その他等に区分しました。医薬品グレード人造樟脳の世界市場概観、メーカー動向、メーカー別医薬品グレード人造樟脳シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・医薬品グレード人造樟脳の市場概観 ・医薬品グレード人造樟脳の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・医薬品グレード人造樟脳の企業別販売動向、市場シェア、市場集中度、競争動向 ・医薬品グレード人造樟脳の世界市場規模 ・医薬品グレード人造樟脳の北米市場分析（アメリカ、カナダ、メキシコ等） ・医薬品グレード人造樟脳のアメリカ市場規模推移 ・医薬品グレード人造樟脳のカナダ市場規模推移 ・医薬品グレード人造樟脳のメキシコ市場規模推移 ・医薬品グレード人造樟脳のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Camphor is conventionally prepared from the extracts of the camphor tree, while the one produced using chemical synthesis is known as synthetic camphor. One of the most important raw material employed in the manufacturing of synthetic camphor is turpentine oil. Pharmaceutical grade synthetic camphor is a high purity product involving more than 98% synthetic camphor and used in manufacturing inhalants (such as nasal decongestants) and topical products (such as muscle rub ointments). Owing to its toxicity, synthetic camphor is not recommended to be administered orally. Scope of the Report: The worldwide market for Pharmaceutical Grade Synthetic Camphor is expected to...

    • ◆H&Iグローバルリサーチのお客様（例）◆